SNDX - Syndax Pharmaceuticals GAAP EPS of -$0.85 beats by $0.12
2024-05-08 07:23:29 ET
More on Syndax Pharmaceuticals
- Syndax Pharmaceuticals: Upcoming Q3 PDUFAs Ignite Hope
- Syndax Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Syndax Pharmaceuticals, Inc. (SNDX) Q4 2023 Earnings Call Transcript
- Crinetics, Syndax gain amid pitch at Sohn charity conference (update)
- FDA grants priority review for Syndax leukemia drug, sets action date